Dr. Stanley F. Chalvire is a Registered Patent Attorney, specializing in patent prosecution, licensing of intellectual property, and related counseling. Stan advises clients in developing and implementing strategies to protect their intellectual property, with a particular focus on clients in the life sciences industry.
Stan counsels clients with respect to the preparation and prosecution of utility patents and design patents, the evaluation of intellectual property portfolios, and regulatory exclusivity matters. Stan also supports clients’ domestic and international licensing initiatives by conducting in-depth due diligence evaluations and by negotiating and drafting a variety of license, development, and supply agreements.
Prior to beginning his legal career Stan practiced as a Registered Pharmacist in both clinical and retail settings, advising physicians and patients with regard to the optimization of drug therapies, the identification and resolution of drug-drug and drug-disease state interactions, and performing drug utilization reviews.
Representative Matters
- Represented Oscient Pharmaceuticals Corporation in its $78 million purchase of the U.S. rights to the cardiovascular drug Antara (fenofibrate) from Reliant Pharmaceuticals.
- Represented Oscient Pharmaceuticals Corporation in its acquisition of worldwide rights to Ramoplanin from Pfizer Inc. subsidiary Vicuron Pharmaceuticals Inc.
- Represented Agrivida, Inc. in its research alliance with Syngenta Ventures to develop advanced crop technology and provide Agrivida access to Syngenta crop technology and intellectual property.
- Represented ETEX Corporation in its sale to Zimmer Holdings, Inc.
- Represented Curadel, Inc. in its in-licensure of imaging technology from Beth Israel Deaconess Medical Center.
- Represented ProQR Therapeutics B.V. in its in-licensure of technology from Massachusetts General Hospital for the treatment of cystic fibrosis.
- Represented Virgin Pulse, Inc. in its in-licensure of trademarks from Virgin Enterprises Limited.
- Represented MacSpeech, Inc., a provider of speech recognition software, in its sale to Nuance Communications.
- Represented Outside The Classroom, Inc., a provider of the largest online alcohol prevention course AlcoholEdu®, in its sale to EverFi, Inc.
Publications
Quoted, Long-standing trademark question before Supreme Court, Massachusetts Lawyers Weekly
Improved Forecast for IP Harvest: Gathering Seeds from USPTO Memo on Vanda
Sandoz Inc. v. Amgen Inc.: Supreme Court Clarifies BPCIA Provisions
Supreme Court Denies Sequenom’s Petition to Clarify Scope of Mayo in Sequenom v. Ariosa
Global Medical Device Regulatory Strategy
A Tangled Web of Post-Patent Expiry Royalty Obligations
United States Completes Hague Agreement Deposit For Industrial Designs
Speaking Engagements
Panelist, Show Me the Money: Bio Bucks, Royalties and Other Payment Structures in Strategic Alliances
Speaker, Cocktails & Conversation with Life Sciences Industry Leaders, Mass Innovation Labs
Panelist, Encore Event! Strategic Alliances: Pot of Gold or Pretty Poison? – Life Sciences Series
Panelist, Strategic Alliances: Pot of Gold or Pretty Poison? – Life Sciences Series – Panel 4
Presenter, Intellectual Property Approaches to Safeguard Value, a Med DevGroup Boston forum
Presenter, Legal Perspectives on Conducting Business in the U.S., swissnex Boston
Presenter, ABC’s for Life Sciences Entrepreneurs: From Start-Up to Exit, CIC series
Presenter, Pharmaceutical Patent Protection and Enforcement Conference in Baltimore, Maryland
Presenter, Power of Trade Secrets: When Not To Patent Your Invention, Med Dev Group
News & Insights
Morse Represents Ranfac Corp. in Medical Device Company Acquisition
COVID-19 Resource Collection
COVID-19 Alert: Prioritized Examination Pilot Program
Inventor Rights Act Proposes to Grant Certain Rights to “Inventor-Owned” Patents
Improved Forecast for IP Harvest
Celebrating Innovation and Evolution: Patent Practice 10th Anniversary
Meet the Patent Team!
Ownership of Arising Inventions in Joint Development Agreements
Czarnecki and Chalvire Elevated Within the Firm
A Tangled Web of Post-Patent Expiry Royalty Obligations
Events
Cocktails & Conversation with Life Sciences Industry Leaders
Encore Event! Strategic Alliances: Pot of Gold or Pretty Poison?
Strategic Alliances: Pot of Gold or Pretty Poison? – Life Sciences Series – Panel 4
Money and Molecules: Early-Stage Life Science Financing
Funding Models in Biotech – Life Sciences Series – Panel 3
Laying the Foundation for Growth: Entity & Equity – Life Sciences Series – Panel 2
Building Your Product & Patent Strategy from the Ground Floor – Life Sciences Series – Panel 1
- MA Rising Stars
2014 – 2015 